| scholarly article | Q13442814 |
| P50 | author | Anderson Miyoshi | Q96250105 |
| P2093 | author name string | Márcio Sousa Jerônimo | |
| Leonora Maciel de Souza Vianna | |||
| Anamelia Lorenzetti Bocca | |||
| Vanessa Bastos Pereira | |||
| Isabel Garcia Sousa | |||
| Marcelo Macedo Brigido | |||
| Andrea Queiroz Maranhão | |||
| Juliana Franco Almeida | |||
| Maria José Chiabai | |||
| Mariana Gabriela Dantas de Azevedo | |||
| Raffael Júnio Araújo de Castro | |||
| Suelen Soares Fernandes | |||
| P2860 | cites work | DNA sequencing with chain-terminating inhibitors | Q22066207 |
| Inflammatory Bowel Disease | Q22248115 | ||
| Heterologously expressed Staphylococcus aureus fibronectin-binding proteins are sufficient for invasion of host cells | Q24548752 | ||
| Faecalibacterium prausnitzii supernatant ameliorates dextran sulfate sodium induced colitis by regulating Th17 cell differentiation | Q24658452 | ||
| Contribution of the IL-17/IL-23 axis to the pathogenesis of inflammatory bowel disease | Q27027429 | ||
| Analyzing real-time PCR data by the comparative C(T) method | Q28131831 | ||
| AVX-470: a novel oral anti-TNF antibody with therapeutic potential in inflammatory bowel disease | Q30565359 | ||
| Temporal and spatial analysis of clinical and molecular parameters in dextran sodium sulfate induced colitis | Q33475620 | ||
| Chemerin aggravates DSS-induced colitis by suppressing M2 macrophage polarization | Q33858362 | ||
| Reassessing the role of Staphylococcus aureus clumping factor and fibronectin-binding protein by expression in Lactococcus lactis. | Q34009366 | ||
| Anti-inflammatory effects of Lactococcus lactis NCDO 2118 during the remission period of chemically induced colitis | Q34018620 | ||
| Lactococcus lactis carrying the pValac DNA expression vector coding for IL-10 reduces inflammation in a murine model of experimental colitis. | Q34030833 | ||
| Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases | Q34181228 | ||
| Role of secretory IgA in the mucosal sensing of commensal bacteria | Q34455427 | ||
| Mice with experimental colitis show an altered metabolism with decreased metabolic rate | Q60413896 | ||
| Neutralization of tumour necrosis factor (TNF) but not of IL-1 reduces inflammation in chronic dextran sulphate sodium-induced colitis in mice | Q73068273 | ||
| Lactococcus lactis, a tool for the delivery of therapeutic proteins treatment of IBD | Q73522161 | ||
| Pharmacokinetics of Lactobacillus plantarum NCIMB 8826, Lactobacillus fermentum KLD, and Lactococcus lactis MG 1363 in the human gastrointestinal tract | Q73883069 | ||
| Remission-inducing effect of anti-TNF monoclonal antibody in TNBS colitis: mechanisms beyond neutralization? | Q79502975 | ||
| PUMA-mediated intestinal epithelial apoptosis contributes to ulcerative colitis in humans and mice. | Q34876574 | ||
| The lactic acid bacteria: a literature survey | Q35052749 | ||
| Interleukin-17 induces an atypical M2-like macrophage subpopulation that regulates intestinal inflammation | Q35276306 | ||
| C-reactive protein as a marker for inflammatory bowel disease | Q35912315 | ||
| Efficient plasmid mobilization by pIP501 in Lactococcus lactis subsp. lactis | Q36122084 | ||
| Use of a human-like low-grade bacteremia model of experimental endocarditis to study the role of Staphylococcus aureus adhesins and platelet aggregation in early endocarditis | Q36646649 | ||
| Drug insight: aminosalicylates for the treatment of IBD. | Q36752659 | ||
| Infliximab and etanercept are equally effective in reducing enterocyte APOPTOSIS in experimental colitis | Q36755033 | ||
| Tumor necrosis factor antagonist mechanisms of action: a comprehensive review | Q37043901 | ||
| Distinct cytokine patterns identified from multiplex profiles of murine DSS and TNBS-induced colitis | Q37098695 | ||
| Lactococcus lactis carrying the pValac eukaryotic expression vector coding for IL-4 reduces chemically-induced intestinal inflammation by increasing the levels of IL-10-producing regulatory cells | Q37220886 | ||
| Dextran sulfate sodium (DSS)-induced colitis in mice | Q37693428 | ||
| A New Broad Range Plasmid for DNA Delivery in Eukaryotic Cells Using Lactic Acid Bacteria: In Vitro and In Vivo Assays | Q37717881 | ||
| Innate and adaptive immunity in inflammatory bowel disease. | Q38115075 | ||
| Multi-faceted functions of secretory IgA at mucosal surfaces | Q38123163 | ||
| Use of native lactococci as vehicles for delivery of DNA into mammalian epithelial cells | Q39108993 | ||
| IBD immunopathogenesis: A comprehensive review of inflammatory molecules | Q39141172 | ||
| Cytokines in inflammatory bowel disease | Q39206254 | ||
| Anti-inflammatory effects of infliximab in mice are independent of tumour necrosis factor α neutralization. | Q39350996 | ||
| Orally administered L. lactis secreting an anti-TNF Nanobody demonstrate efficacy in chronic colitis | Q39793093 | ||
| Acute colitis induced by dextran sulfate sodium progresses to chronicity in C57BL/6 but not in BALB/c mice: correlation between symptoms and inflammation. | Q40456395 | ||
| Hsp65-Producing Lactococcus lactis Prevents Inflammatory Intestinal Disease in Mice by IL-10- and TLR2-Dependent Pathways | Q41867495 | ||
| Lactococcus lactis expressing either Staphylococcus aureus fibronectin-binding protein A or Listeria monocytogenes internalin A can efficiently internalize and deliver DNA in human epithelial cells | Q42116538 | ||
| Th17 cells upregulate polymeric Ig receptor and intestinal IgA and contribute to intestinal homeostasis | Q42409798 | ||
| Clinicopathologic study of dextran sulfate sodium experimental murine colitis. | Q42506472 | ||
| A new plasmid vector for DNA delivery using lactococci | Q43176145 | ||
| IL23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn's disease | Q43964285 | ||
| Protective role of arginase in a mouse model of colitis | Q44690397 | ||
| A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice | Q44753508 | ||
| In vivo transfer of plasmid from food-grade transiting lactococci to murine epithelial cells | Q45876837 | ||
| The variegated aspects of Immunoglobulin A. | Q46561688 | ||
| Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. | Q47758448 | ||
| Locally injected Infliximab ameliorates murine DSS colitis: differences in serum and intestinal levels of drug between healthy and colitic mice. | Q47869617 | ||
| Enhanced intestinal inflammation induced by dextran sulfate sodium in tumor necrosis factor-alpha deficient mice | Q47965961 | ||
| IgA Function in Relation to the Intestinal Microbiota. | Q50063230 | ||
| Chemically induced mouse models of acute and chronic intestinal inflammation. | Q50966061 | ||
| TH17 cell induction and effects of IL-17A and IL-17F blockade in experimental colitis. | Q50977622 | ||
| Dextran sulphate sodium colitis in C57BL/6J mice is alleviated by Lactococcus lactis and worsened by the neutralization of Tumor necrosis Factor α. | Q51224777 | ||
| Preclinical Development of a Novel, Orally-Administered Anti-Tumour Necrosis Factor Domain Antibody for the Treatment of Inflammatory Bowel Disease. | Q52643911 | ||
| A new therapeutic association to manage relapsing experimental colitis: Doxycycline plus Saccharomyces boulardii. | Q52947995 | ||
| In-vivo monitoring of acute DSS-Colitis using Colonoscopy, high resolution Ultrasound and bench-top Magnetic Resonance Imaging in Mice. | Q53504354 | ||
| A New Venue of TNF Targeting. | Q55001725 | ||
| Genetically modified bacteria enlisted in fight against disease | Q57407181 | ||
| P433 | issue | 1 | |
| P921 | main subject | Lactococcus lactis | Q133598 |
| P304 | page(s) | 38 | |
| P577 | publication date | 2019-06-25 | |
| P1433 | published in | BMC Biotechnology | Q15753225 |
| P1476 | title | Mucosal delivery of Lactococcus lactis carrying an anti-TNF scFv expression vector ameliorates experimental colitis in mice | |
| P478 | volume | 19 |
| Q89983343 | Genome-scale exploration of transcriptional regulation in the nisin Z producer Lactococcus lactis subsp. lactis IO-1 |
| Q96293717 | Recombinant invasive Lactobacillus plantarum expressing the Eimeria tenella fusion gene TA4 and AMA1 induces protection against coccidiosis in chickens |
Search more.